Wallentin L - Search Results

1

Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.

Stenestrand U, Wallentin L; Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Stenestrand U, et al. Among authors: wallentin l. Arch Intern Med. 2003 Apr 28;163(8):965-71. doi: 10.1001/archinte.163.8.965. Arch Intern Med. 2003. PMID: 12719207

2

Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study.

Stenestrand U, Wallentin L. Stenestrand U, et al. Among authors: wallentin l. Lancet. 2002 May 25;359(9320):1805-11. doi: 10.1016/S0140-6736(02)08710-X. Lancet. 2002. PMID: 12044375

3

Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.

Norhammar A, Malmberg K, Rydén L, Tornvall P, Stenestrand U, Wallentin L; Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Norhammar A, et al. Among authors: wallentin l. Eur Heart J. 2003 May;24(9):838-44. doi: 10.1016/s0195-668x(02)00828-x. Eur Heart J. 2003. PMID: 12727151

4

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.

James S, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L, Lindahl B. James S, et al. Among authors: wallentin l. Am J Med. 2003 Aug 15;115(3):178-84. doi: 10.1016/s0002-9343(03)00348-6. Am J Med. 2003. PMID: 12935823 Clinical Trial.

5

Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction.

Björklund E, Lindahl B, Johanson P, Jernberg T, Svensson AM, Venge P, Wallentin L, Dellborg M; ASSENT-2 and ASSENT-PLUS Study Groups. Björklund E, et al. Among authors: wallentin l. Eur Heart J. 2004 Jan;25(2):113-20. doi: 10.1016/j.ehj.2003.10.025. Eur Heart J. 2004. PMID: 14720527 Clinical Trial.

6

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.

Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Rydén L, Wallentin L. Norhammar A, et al. Among authors: wallentin l. J Am Coll Cardiol. 2004 Feb 18;43(4):585-91. doi: 10.1016/j.jacc.2003.08.050. J Am Coll Cardiol. 2004. PMID: 14975468 Free article. Clinical Trial.

7

ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy.

Johanson P, Wallentin L, Nilsson T, Bergstrand L, Lindahl B, Dellborg M. Johanson P, et al. Among authors: wallentin l. Am Heart J. 2004 May;147(5):853-8. doi: 10.1016/j.ahj.2003.11.008. Am Heart J. 2004. PMID: 15131542

8

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.

Sinnaeve PR, Alexander JH, Bogaerts K, Belmans A, Wallentin L, Armstrong P, Adgey JA, Tendera M, Diaz R, Soares-Piegas L, Vahanian A, Granger CB, Van De Werf FJ. Sinnaeve PR, et al. Among authors: wallentin l. Am Heart J. 2004 Jun;147(6):993-8. doi: 10.1016/j.ahj.2003.12.028. Am Heart J. 2004. PMID: 15199346 Clinical Trial.

9

Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block.

Stenestrand U, Tabrizi F, Lindbäck J, Englund A, Rosenqvist M, Wallentin L. Stenestrand U, et al. Among authors: wallentin l. Circulation. 2004 Oct 5;110(14):1896-902. doi: 10.1161/01.CIR.0000143136.51424.38. Epub 2004 Sep 27. Circulation. 2004. PMID: 15451802

10

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial.

Björklund E, Lindahl B, Stenestrand U, Swahn E, Dellborg M, Pehrsson K, Van De Werf F, Wallentin L; Swedish ASSENT-2; RIKS-HIA Investigators. Björklund E, et al. Among authors: wallentin l. Am Heart J. 2004 Oct;148(4):566-73. doi: 10.1016/j.ahj.2004.04.014. Am Heart J. 2004. PMID: 15459584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

835 results

Search Page